phosphorylase kinase

phosphorylase kinase
Name	Phosphorylase kinase
Ec number	2.7.11.9
Other names	Phosphorylase b kinase

phosphorylase kinase

Phosphorylase kinase is a large, multimeric serine/threonine protein kinase that activates glycogen phosphorylase by phosphorylation, thereby regulating glycogen breakdown. It integrates signaling from hormones such as epinephrine and glucagon via protein kinase A, and from calcium-mediated pathways linked to muscle contraction and the sarcoplasmic reticulum. The enzyme's activity is essential in tissues with dynamic energy demands and is implicated in inherited metabolic diseases and regulatory pathways studied across biochemistry, cell biology, and physiology.

Introduction

Phosphorylase kinase was first characterized in studies of glycogen phosphorylase regulation during the 1950s and 1960s when researchers at institutions like Harvard University and University of Cambridge delineated hormonal control of glycogenolysis. Subsequent work by investigators connected phosphorylase kinase to cascades involving adenylate cyclase, cyclic AMP, and protein kinase A (PKA), while structural studies leveraged methods developed at facilities such as Brookhaven National Laboratory and European Molecular Biology Laboratory. The enzyme remains central in research on metabolic disorders, signal transduction, and enzymology at centers including National Institutes of Health and university laboratories worldwide.

Structure and subunit composition

Phosphorylase kinase is a tetramer of heterotetramers, organized as (αβγδ)4, giving a high molecular weight complex first estimated by analytical centrifugation and later resolved by cryo-electron microscopy performed at facilities like Max Planck Institute and MRC Laboratory of Molecular Biology. The α and β subunits (encoded by genes such as PHKA1, PHKA2, PHKB) are large regulatory proteins that are substrates for protein kinase A; the γ subunit contains the catalytic kinase domain related to the CAMK family; the δ subunit is identical to calmodulin, a calcium sensor discovered in research from University of California, Berkeley and characterized by labs including that of Martin Rodbell. High-resolution structures have been informed by techniques developed at institutes like the European Synchrotron Radiation Facility and reliance on protein databases maintained by organizations such as the Protein Data Bank.

Mechanism and regulation

The catalytic γ subunit phosphorylates glycogen phosphorylase on a specific serine residue using ATP as phosphate donor, employing a mechanism similar to other serine/threonine kinases characterized in canonical signaling pathways like those studied for MAP kinase and PKA. Regulation is multimodal: phosphorylation of α and β by protein kinase A increases activity; calcium binding to the δ subunit (calmodulin) triggers conformational change during events such as skeletal muscle contraction mediated by troponin and ryanodine receptor signaling; and interactions with regulatory proteins and glycogen particles modulate localization, as described in studies from laboratories at University of Oxford and Stanford University. Allosteric control and feedback from metabolites intersect with pathways involving insulin and AMP-activated protein kinase (AMPK).

Physiological roles and tissue distribution

Phosphorylase kinase plays critical roles in hepatic glycogenolysis to maintain blood glucose levels during fasting, in skeletal muscle to support rapid ATP generation during exercise and sympathetic activation, and in cardiac tissue where regulation of energy supply is vital during stress responses examined by investigators at centers such as Cleveland Clinic and Johns Hopkins University. Tissue-specific isoforms arise from distinct genes and alternative splicing, producing variation in regulatory properties across organs, a concept explored in comparative studies at institutions like Cold Spring Harbor Laboratory and Karolinska Institutet. The enzyme participates in coordinated responses with hormones including glucagon and epinephrine, and with intracellular calcium fluxes controlled by the sarcoplasmic reticulum.

Clinical significance and associated disorders

Mutations in phosphorylase kinase subunit genes cause glycogen storage disease type IX variants, identified in clinical genetics programs at hospitals such as Mayo Clinic and Guy's Hospital. Presentations range from hepatomegaly and growth retardation to exercise intolerance and myopathy, with phenotypic descriptions appearing in case series from centers like National Health Service clinics and university hospitals. Diagnosis employs biochemical assays and genetic testing performed at molecular diagnostics laboratories affiliated with institutions including Children's Hospital of Philadelphia and Mount Sinai Hospital. Research into therapeutic approaches interfaces with fields represented by pharmacology groups at industry and academic labs, and clinical trials coordinated by organizations such as the European Medicines Agency and Food and Drug Administration.

Experimental methods and assays

Biochemical characterization uses activity assays measuring incorporation of 32P or nonradioactive phosphate into glycogen phosphorylase substrates, techniques refined in protocols from laboratories at Imperial College London and University of Toronto. Structural analysis employs cryo-EM, X-ray crystallography, and small-angle X-ray scattering at synchrotrons like Diamond Light Source and computational modeling using resources from European Bioinformatics Institute. Genetic studies utilize next-generation sequencing platforms developed by companies such as Illumina and analytical pipelines originating from projects like the Human Genome Project. Functional studies in cells and animal models use transgenic mice created in facilities like Jackson Laboratory and gene editing technologies pioneered by researchers at Broad Institute.

Category:Enzymes